- Home
- CNK vs PRCT Comparison
CNK vs PRCT Comparison
Compare CNK & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNK
- PRCT
- Stock Information
- Founded
- CNK 1984
- PRCT 2009
- Country
- CNK United States
- PRCT United States
- Employees
- CNK N/A
- PRCT N/A
- Industry
- CNK Movies/Entertainment
- PRCT Medical Specialities
- Sector
- CNK Consumer Discretionary
- PRCT Health Care
- Exchange
- CNK Nasdaq
- PRCT Nasdaq
- Market Cap
- CNK 3.2B
- PRCT 3.2B
- IPO Year
- CNK 2007
- PRCT 2021
- Fundamental
- Price
- CNK $25.69
- PRCT $49.95
- Analyst Decision
- CNK Buy
- PRCT Buy
- Analyst Count
- CNK 13
- PRCT 8
- Target Price
- CNK $33.46
- PRCT $86.14
- AVG Volume (30 Days)
- CNK 4.4M
- PRCT 1.2M
- Earning Date
- CNK 08-01-2025
- PRCT 08-06-2025
- Dividend Yield
- CNK 1.25%
- PRCT N/A
- EPS Growth
- CNK 86.03
- PRCT N/A
- EPS
- CNK 1.92
- PRCT N/A
- Revenue
- CNK $3,217,300,000.00
- PRCT $249,121,000.00
- Revenue This Year
- CNK $8.41
- PRCT $47.38
- Revenue Next Year
- CNK $7.74
- PRCT $31.71
- P/E Ratio
- CNK $13.36
- PRCT N/A
- Revenue Growth
- CNK 13.80
- PRCT 59.36
- 52 Week Low
- CNK $23.12
- PRCT $47.04
- 52 Week High
- CNK $36.28
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- CNK 23.83
- PRCT 33.64
- Support Level
- CNK $29.55
- PRCT $51.00
- Resistance Level
- CNK $28.49
- PRCT $60.57
- Average True Range (ATR)
- CNK 1.06
- PRCT 3.33
- MACD
- CNK -0.38
- PRCT -0.95
- Stochastic Oscillator
- CNK 10.21
- PRCT 18.82
About CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.